Buy Veru Stock | FHCO Stock Price & Latest News | Public.com
FHCO

Veru

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Veru (FHCO) stock trends here

    About FHCO

    Veru, Inc. is an oncology biopharmaceutical company engaged in developing novel medicines for the management of prostate cancer and breast cancer. Its prostate cancer drug candidates include: VERU-111, an oral alpha and beta tubulin inhibitor, which is in a Phase 2 clin...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$712,32M
    Volume
    Price-to-Earnings Ratio45,450.00
    Dividend Rate
    Dividend Yield
    1 Year High$24.57
    1 Year Low$2.30
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app